FDA Inspection
Global Life ResearchGlobal Life Research – FDA Inspection, May 19, 2016
Record Details
This FDA Inspection record concerns Global Life Research, with an inspection on May 19, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Global Life Research
- Inspection Date
- May 19, 2016
- Product Type
- Biologics
View Company Profile
ID · e8f61d32-c84d-4829-a282-d273f5667289
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 980569
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 600.10(b)Personnel capabilities
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.100(b)SOPs for investigations, records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Global Life Research
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 15, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Global Life Research
- FDA Inspection 1120394 - 2020-02-14
- FDA Inspection 1085846 - 2019-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.